In particular, in comparison to C-peptide, ghrelin, GIP, insulin and adiponectin, it is worth noting that CXCL9, HGF and glucagon levels are increased in CHD patients even if they were resulted significant in patients affected by one only disease. This evidence concerns the gene CXCL9 and coronary artery disorder.